BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 36352460)

  • 1. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.
    Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL
    Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
    Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
    Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
    Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
    Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes.
    Aggarwala V; Mogno I; Li Z; Yang C; Britton GJ; Chen-Liaw A; Mitcham J; Bongers G; Gevers D; Clemente JC; Colombel JF; Grinspan A; Faith J
    Nat Microbiol; 2021 Oct; 6(10):1309-1318. PubMed ID: 34580445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
    Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
    Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
    He R; Li P; Wang J; Cui B; Zhang F; Zhao F
    Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with
    Varga A; Makszin L; Bufa A; Sipos D; Kása P; Pál S; Rosenstiel P; Sommer F; Kocsis B; Péterfi Z
    Front Cell Infect Microbiol; 2023; 13():1041384. PubMed ID: 36756616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Ianiro G; Punčochář M; Karcher N; Porcari S; Armanini F; Asnicar F; Beghini F; Blanco-Míguez A; Cumbo F; Manghi P; Pinto F; Masucci L; Quaranta G; De Giorgi S; Sciumè GD; Bibbò S; Del Chierico F; Putignani L; Sanguinetti M; Gasbarrini A; Valles-Colomer M; Cammarota G; Segata N
    Nat Med; 2022 Sep; 28(9):1913-1923. PubMed ID: 36109637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection.
    Nooij S; Vendrik KEW; Zwittink RD; Ducarmon QR; Keller JJ; Kuijper EJ; Terveer EM;
    Genome Med; 2024 Feb; 16(1):37. PubMed ID: 38419010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.
    Drewes JL; Corona A; Sanchez U; Fan Y; Hourigan SK; Weidner M; Sidhu SD; Simner PJ; Wang H; Timp W; Oliva-Hemker M; Sears CL
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation.
    Smillie CS; Sauk J; Gevers D; Friedman J; Sung J; Youngster I; Hohmann EL; Staley C; Khoruts A; Sadowsky MJ; Allegretti JR; Smith MB; Xavier RJ; Alm EJ
    Cell Host Microbe; 2018 Feb; 23(2):229-240.e5. PubMed ID: 29447696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation.
    Podlesny D; Arze C; Dörner E; Verma S; Dutta S; Walter J; Fricke WF
    Microbiome; 2022 Mar; 10(1):53. PubMed ID: 35337386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.